Sex-Specific Regulation of Inflammation and Metabolic Syndrome in Obesity.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsTer Horst, Rob
van den Munckhof, Inge C L
Smeekens, Sanne P
Galesloot, Tessel E
de Graaf, Jacqueline
Xavier, Ramnik J
Joosten, Leo A B
Rutten, Joost H W
Netea, Mihai G
Riksen, Niels P
MetadataShow full item record
AbstractMetabolic dysregulation and inflammation are important consequences of obesity and impact susceptibility to cardiovascular disease. Anti-inflammatory therapy in cardiovascular disease is being developed under the assumption that inflammatory pathways are identical in women and men, but it is not known if this is indeed the case. In this study, we assessed the sex-specific relation between inflammation and metabolic dysregulation in obesity. Approach and Results: Three hundred two individuals were included, half with a BMI 27 to 30 kg/m2 and half with a BMI>30 kg/m2, 45% were women. The presence of metabolic syndrome was assessed according to the National Cholesterol Education Program-ATPIII criteria, and inflammation was studied using circulating markers of inflammation, cell counts, and ex vivo cytokine production capacity of isolated immune cells. Additionally, lipidomic and metabolomic data were gathered, and subcutaneous fat biopsies were histologically assessed. Metabolic syndrome is associated with an increased inflammatory profile that profoundly differs between women and men: women with metabolic syndrome show a lower concentration of the anti-inflammatory adiponectin, whereas men show increased levels of several pro-inflammatory markers such as IL (interleukin)-6 and leptin. Adipose tissue inflammation showed similar sex-specific associations with these markers. Peripheral blood mononuclear cells isolated from men, but not women, with metabolic syndrome display enhanced cytokine production capacity.
CitationArterioscler Thromb Vasc Biol. 2020;40(7):1787-1800. doi:10.1161/ATVBAHA.120.314508.
AffiliationCiiM, Zentrum für individualisierte Infektionsmedizin, Feodor-Lynen-Str.7, 30625 Hannover.
PublisherLippincott, Williams & Wilkins
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
- Authors: Hung J, McQuillan BM, Thompson PL, Beilby JP
- Issue date: 2008 May
- Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
- Authors: Siemińska L, Wojciechowska C, Walczak K, Borowski A, Marek B, Nowak M, Kajdaniuk D, Foltyn W, Kos-Kudła B
- Issue date: 2015
- The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
- Authors: Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho FC, Netto BD, Carvalho-Ferreira JP, Oyama LM, Nascimento CM, de Mello MT, Tufik S, Dâmaso AR
- Issue date: 2015 Jun 28
- Influence of visceral obesity on the secretion of adipokines with epicardial adipocytes in patients with coronary heart disease.
- Authors: Gruzdeva OV, Borodkina AD, Akbasheva OE, Dileva YA, Antonova LV, Matveeva VG, Uchasova EG, Ivanov SV, Belik EV, Fanaskova EV, Karetnikova VN, Kokov AN, Barbarash OL
- Issue date: 2018 Nov 22
- Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
- Authors: Tankó LB, Christiansen C
- Issue date: 2006 Jun